TMO
Thermo Fisher Scientific
$243.20Bn
657.76
+0.93%
+23.02%
The company's Life Sciences Solutions and Analytical Instruments segments provide a vast portfolio of reagents, instruments, and consumables for biological and medical research, genomic and proteomic analysis, and electron microscopy. These products are sold to universities, research institutions, and biotech firms to support scientific research and bioproduction.
DHR
Danaher
$154.53Bn
219.85
+1.10%
+7.52%
Danaher's Life Sciences and Biotechnology segments provide instruments, consumables, and software for bioprocessing, genomics, and proteomics used in laboratory research and biopharmaceutical manufacturing. These products are sold to research institutions and biotech companies to study biological molecules like DNA and RNA.
BDX
2nd
Becton Dickinson
$50.05Bn
183.76
+0.57%
+23.62%
BD sells research and clinical tools for the study of cells, including fluorescence-activated cell sorters, analyzers, and reagents for life science research.
A
Agilent Technologies
$48.07Bn
170.48
+1.37%
+21.68%
Agilent designs and manufactures life-sciences research tools and instruments, including liquid chromatography, gas chromatography, and mass spectrometry systems. These products are sold to pharmaceutical, biotechnology, and academic research institutions for drug discovery and chemical analysis.
WAT
Waters
$42.60Bn
433.73
+1.02%
+31.25%
Waters Corporation designs and manufactures analytical instruments, including HPLC, UPLC, and mass spectrometry systems, as well as chromatography columns and reagents. These products are sold as tools for life-sciences research and bioproduction to customers in pharmaceuticals, biotechnology, and academic research.
ILMN
Illumina
$42.00Bn
278.17
+5.14%
+188.41%
Illumina designs and manufactures sequencing and array-based instruments, reagents, and library preparation kits used for genomics and proteomics research. Its primary revenue comes from selling these life-sciences research tools and consumables to research institutions, academic centers, and biotechnology companies.
IDXX
2nd
Idexx Laboratories
$40.86Bn
518.00
+0.95%
-17.61%
Idexx sells health monitoring and biological materials testing products specifically for biomedical research customers and research institutions.
MTD
2nd
Mettler Toledo International
$33.63Bn
1,551.09
+1.53%
+18.62%
Mettler-Toledo designs and manufactures laboratory instruments, including balances, pipettes, and analyzers, which contribute approximately 56% of net sales and are used in life sciences research and development.
IR
2nd
Ingersoll Rand
$30.55Bn
78.74
+0.94%
+0.33%
The Precision and Science Technologies segment designs and manufactures life science tools and single-use powder and liquid handling containment solutions for life science and medical applications.
STE
2nd
Steris
$20.91Bn
214.43
+1.79%
-10.44%
The Life Sciences segment provides pharmaceutical detergents, cleanroom disinfectants, and research sterilizers specifically for biopharmaceutical and medical device manufacturing facilities.
RVTY
Revvity
$17.20Bn
154.15
+1.37%
+68.18%
Revvity's Life Sciences segment sells a comprehensive portfolio of research tools, including radiometric detection reagents, microscopy imaging reagents, recombinant cell lines, and automated liquid handling platforms to pharmaceutical, biotech, and academic researchers.
CRL
2nd
Charles River Laboratories International
$14.40Bn
301.73
+1.21%
+75.28%
The Research Models and Services segment supplies purpose-bred rodents, large research models, and cell solutions used by clients for drug discovery and development activities.
TECH
Bio-Techne
$11.31Bn
72.46
+0.01%
+20.97%
Bio-Techne's Protein Sciences segment sells high-quality biological reagents such as cytokines, growth factors, and antibodies, as well as proteomic analytical tools like western blot systems and multiplexed ELISA platforms for life science research and drug discovery.
TXG
10x Genomics
$10.51Bn
80.65
+4.36%
+588.73%
10x Genomics develops and sells instruments and consumables for life-sciences research, specifically the Chromium single cell platform and Visium and Xenium spatial platforms. Its customers include academic research institutions, government laboratories, and biotechnology firms using these tools for biological analysis.
DCI
2nd
Donaldson
$10.08Bn
86.93
-0.24%
+6.74%
The Life Sciences segment sells bioprocessing equipment such as bioreactors and fermenters, as well as consumables including chromatography devices and reagents used for cell growth, separation, and purification.
TWST
Twist Bioscience
$10.01Bn
159.78
+5.08%
+401.03%
Twist Bioscience manufactures and sells synthetic genes, oligonucleotides, and next-generation sequencing tools (such as target enrichment probes and library preparation kits) used for research and bioproduction. These products are sold to biotech, pharma, and academic laboratories for applications like drug discovery and basic biological investigation.
QGEN
Qiagen
$9.85Bn
45.39
+1.93%
-3.28%
QIAGEN provides tools, reagents, and consumables for life-sciences research, such as the QIAamp and QIAcube systems for DNA/RNA extraction. Its customer base includes academic research institutions and pharmaceutical and biotechnology companies engaged in drug discovery.
RGEN
Repligen
$9.81Bn
173.88
+6.13%
+16.85%
Repligen provides bioprocessing technologies, instruments, and consumables used in the manufacturing of biological drugs, such as XCell ATF cell retention systems and OPUS PrePacked Columns. Its revenue is generated from the sale of these life-sciences research and bioproduction tools to biopharmaceutical companies and CDMOs.
BIO
Bio-Rad Laboratories
$9.79Bn
366.21
+1.64%
+21.81%
Bio-Rad's Life Science segment develops and markets instruments, systems, reagents, and consumables used to separate, purify, and quantify biological materials for research and biopharmaceutical manufacturing. These products are sold to universities, medical schools, and biotechnology companies for use in laboratory environments.
BRKR
Bruker
$8.96Bn
58.84
+1.59%
+63.76%
Bruker's core business is the development and manufacture of high-performance scientific instruments for life sciences research, including mass spectrometry (timsTOF), nuclear magnetic resonance (NMR) systems, and spatial biology platforms (CosMx). These tools are sold to academic, government, pharmaceutical, and biotechnology customers for molecular and cellular research.
GRAL
2nd
Grail
$6.28Bn
140.58
+6.01%
+97.64%
GRAIL generates income from 'research use only' offerings and collaborations with biopharmaceutical partners for biomarker discovery and minimal residual disease monitoring.
GRFS
2nd
Grifols
$5.08Bn
7.46
+0.67%
-21.39%
Through its Bio Supplies segment, the company sells biological materials, cell culture media, and stem cell reagents to biotechnology companies and academic institutions for research and manufacturing.
PGEN
2nd
Precigen
$2.80Bn
7.81
+2.76%
+144.83%
Through its Exemplar subsidiary, the company sells genetically engineered porcine research models to academic and industry customers for use in drug discovery and preclinical studies.
MRVI
Maravai Lifesciences Holdings
$1.93Bn
7.44
+3.19%
+125.45%
Maravai sells complex nucleic acids, custom enzymes, and antibody-based solutions used for research and biopharmaceutical production. These products, including mRNA oligonucleotides and nucleoside triphosphates, are sold to biopharmaceutical companies, biotech firms, and academic research institutions as life-sciences research tools and bioprocessing supplies.
BLFS
Biolife Solutions
$1.89Bn
38.61
+0.00%
+46.81%
Biolife Solutions provides tools, reagents, and consumables for bioproduction and life-sciences research, specifically biopreservation media like HypoThermosol® FRS and CryoStor® Freeze Media. Its customers include academic research institutions and biopharma manufacturers using these tools for basic and applied research.
AZTA
Azenta
$1.65Bn
37.72
+4.78%
+18.88%
Azenta sells a broad portfolio of life sciences research tools, including automated storage systems, cryogenic systems, and consumables like racks, tubes, and plates. These products are sold to pharmaceutical, biotechnology, and academic research institutions for sample exploration and management.
NKTR
2nd
Nektar Therapeutics
$1.36Bn
41.17
+0.91%
-26.01%
The company historically generated revenue from the sale of its proprietary polyethylene glycol (PEG) reagents, which are tools used in bioproduction and life-sciences research to enhance drug pharmacokinetics.
CYRX
2nd
Cryoport
$878.75Mn
17.35
+2.66%
+74.55%
Cryoport provides bioprocessing and research-related tools through its IntegriCell cryopreservation services and BioStorage solutions used for preclinical and early-stage clinical materials.
DNA
2nd
Ginkgo Bioworks Holdings
$828.88Mn
13.01
+14.63%
-14.63%
The company sells standardized tools and data assets, such as RAC systems and Datapoints, which are used for life-sciences research and bioproduction.
PACB
Pacific Biosciences Of California
$724.19Mn
2.33
+1.30%
+52.29%
Pacific Biosciences designs and manufactures sequencing instruments such as the Revio, Vega, and Sequel platforms, as well as proprietary consumables like SMRT cells and reagent kits. These products are sold to academic, governmental, and commercial research institutions for life-sciences research and genomic analysis.
MLAB
Mesa Laboratories
$713.52Mn
127.51
+1.15%
+77.94%
Mesa Laboratories designs and manufactures life sciences tools, including the MassARRAY system for genomic testing and Gyrolab systems for protein analysis and peptide synthesis. These products, along with their associated chips, panels, and reagents, are sold to biopharma R&D teams, academic laboratories, and clinical research labs.
CTKB
Cytek Biosciences
$705.81Mn
5.43
+1.31%
+37.82%
Cytek Biosciences develops and sells flow cytometry instruments, such as the Aurora and Northern Lights systems, and reagents like cFluor and Tonbo for high-dimensional single cell analysis. Its primary customers are pharmaceutical companies, biopharma firms, and academic research centers using these tools for drug discovery and research in oncology and immunology.
OABI
2nd
OmniAb
$696.42Mn
4.79
+2.79%
+163.19%
Through its xPloration segment, the company sells instruments and related consumables used in antibody discovery and optimization workflows to external customers.
TKNO
Alpha Teknova
$474.55Mn
8.84
+4.74%
+75.05%
Alpha Teknova manufactures and sells reagents, pre-poured media plates, and liquid microbial culture media used for life-sciences research and bioproduction. Its Lab Essentials segment, which contributes 76.6% of revenue, specifically provides RUO formulations for applications like next generation sequencing and spatial biology.
MASS
2nd
908 Devices
$458.61Mn
12.05
+4.33%
+36.93%
The company sells its handheld chemical analysis devices to life science researchers for laboratory and field work, providing tools for research and bioproduction analysis.
QSI
Quantum-Si
$304.39Mn
1.53
+25.41%
-12.07%
Quantum-Si sells the Platinum and Platinum Pro protein sequencers, as well as consumable kits (Library Preparation, Barcoding, and Sequencing Kits), which are tools and reagents used for life-sciences research in proteomics. Its customers include academic research institutions, biopharmaceutical companies, and industrial laboratories using the platform for biomarker discovery and vaccine development.
NAUT
Nautilus Biotechnology
$286.26Mn
2.25
+23.63%
+150.00%
Nautilus Biotechnology develops the Nautilus Voyager system, which is a life-sciences research tool for single molecule protein analysis. The company targets academic, biopharmaceutical, and research institutions for drug discovery and basic biology, selling instruments and recurring consumables like flow cells and reagent kits.
OSUR
2nd
Orasure Technologies
$274.52Mn
3.90
+2.63%
+25.00%
The Sample Management Solutions segment sells tools, reagents, and consumables such as Oragene and ORAcollect kits for genomics, proteomics, and microbiome research to academic labs and biotech companies.
LAB
Standard Biotools
$270.56Mn
0.69
+2.99%
-49.26%
Standard BioTools develops and sells instrumentation, consumables, and reagents for proteomics and genomics research, specifically through its CyTOF, Hyperion, and Biomark platforms. Its customers are research institutions and biopharmaceutical companies, and the profile explicitly states its products are marketed for research use only and not for clinical diagnostics.
SEER
Seer
$242.82Mn
2.19
+0.92%
-5.19%
Seer sells the Proteograph Product Suite, which consists of life-sciences research tools including the SP200 automation instrument and consumable assays (Proteograph ONE and DIRECT) used for deep proteomic analysis. These products are sold to academic institutions and biopharmaceutical companies for basic research and biomarker discovery.
LFCR
2nd
Lifecore Biomedical, Inc. \De\
$238.82Mn
6.45
+0.31%
-2.71%
The company manufactures and sells pharmaceutical grade non-animal sourced hyaluronic acid (HA) in bulk form as a raw material for customers' use in various medical applications.
QTRX
Quanterix
$154.60Mn
3.28
+2.18%
-45.24%
Quanterix primarily sells life-sciences research tools, including the Simoa and Spatial Biology instruments (HD-X, SR-X, SP-X, PhenoCycler), as well as the associated assay kits, consumables, and reagents used by academic research labs and biopharmaceutical firms.
CDXS
Codexis
$128.86Mn
1.41
+3.68%
-47.39%
Codexis sells engineered enzymes and proteins as biocatalysts and provides the CodeEvolver technology platform for bioproduction. Its revenue is derived from the sale of these research and production tools to pharmaceutical and biotechnology firms.
MXCT
Maxcyte
$107.20Mn
1.01
-0.98%
-37.65%
MaxCyte sells the ExPERT family of instruments, proprietary processing assemblies (PAs), and consumables like electroporation buffers used for cell engineering and bioproduction. These products are sold to biopharmaceutical companies, academic institutions, and government research organizations for life-sciences research and development.
ALPS
Alps
$61.57Mn
0.37
+0.00%
—
Alps Life Sciences Inc is engaged in the research, development, and commercialization of life sciences products and services, serving research institutions, laboratories, and biotechnology firms. This aligns with the provision of tools and reagents for life-sciences research and bioproduction.
JANL
2nd
Janel
$60.53Mn
51.02
+0.00%
+41.68%
The Life Sciences segment manufactures and distributes antibodies and research and diagnostic reagents for academic, non-profit, and commercial customers, which are tools used for life-sciences research.
SGMOQ
2nd
Sangamo Therapeutics
$42.03Mn
0.15
+7.14%
-79.73%
The company explicitly expects to receive additional income from licensing its technology to other industries, specifically mentioning research reagents.
RPID
2nd
Rapid Micro Biosystems
$40.46Mn
0.89
+3.49%
-75.21%
The company provides automation solutions and tools for microbial quality control used in pharmaceutical manufacturing and bioproduction. Its systems are used by manufacturers of cell and gene therapies to ensure product quality during the production process.
HBIO
Harvard Bioscience
$37.51Mn
8.24
+1.35%
+87.27%
Harvard Bioscience develops and manufactures instruments, reagents, and consumables for life-sciences research, such as spectrophotometers, amino acid analyzers, and electroporation systems. Its products are sold to academic institutions and pharmaceutical companies for use in early discovery and bioproduction.
IMMP
2nd
Immutep
$26.51Mn
3.63
-5.47%
+78.82%
The company generates income through its subsidiary, Immutep S A S, which manufactures and distributes research reagents to scientists via third-party distributors such as Adipogen and Enzo.
VRXA
2nd
Veraxa Biotech AG - Post de-SPAC
$18.24Mn
1.26
+15.60%
-87.97%
The company operates the Hitmaster Microfluidics Platform, which provides high-throughput antibody discovery, single-cell analysis, and precision sorting of biological particles for research and diagnostic applications.
BNGO
Bionano Genomics
$16.84Mn
1.43
-2.05%
-32.86%
Bionano Genomics sells optical genome mapping instruments like the Saphyr and Stratys systems, along with the consumables and reagents required to operate them. These products are sold to academic research institutions and biotechnology companies for life-sciences research and genomic analysis.
DYAI
2nd
Dyadic International
$16.03Mn
0.44
+0.00%
-61.06%
The company sells life science reagents such as albumin, transferrin, and DNase I, and serves life science researchers and diagnostic manufacturers.
SCND
Scientific Industries
$8.11Mn
0.68
+0.00%
-6.85%
Scientific Industries designs and manufactures benchtop laboratory equipment and bioprocessing systems, such as biomass monitoring sensors and moisture analyzers, sold to universities and pharmaceutical companies for research. These products, including the DOTS brand platform and Torbal balances, are classic life-sciences research tools and bioprocessing supplies.
ADVB
2nd
Advanced Biomed
$7.89Mn
5.71
-6.70%
-40.27%
The company targets research institutions with its microfluidic technology platforms and related products for oncology detection.
CDIO
2nd
Cardio Diagnostics Holdings
$5.53Mn
1.87
+0.54%
-58.90%
The company provides research use only kits under the CardioInnovate360 brand specifically to support biopharmaceutical development.
CLGN
2nd
CollPlant Biotechnologies
$4.49Mn
3.51
-11.36%
-85.00%
CollPlant sells bioinks, collagen solutions, and rhCollagen to research institutions, academic laboratories, and STEMCELL Technologies for use in cell culture media kits and life-sciences research.
POAS
2nd
Phaos Technology Holdings (Cayman)
$4.42Mn
0.14
+0.00%
—
The company sells the PT-Biology (PT-B) series and other super-resolution imagers to R&D institutions and biomedical service providers for research and innovation activities. These products serve as life-sciences research tools for observing details beyond the conventional optical limit.
RSCF
Reflect Scientific
$4.28Mn
0.05
-16.67%
-16.67%
Reflect Scientific manufactures and sells specialized equipment for the life science market, specifically ultra-low temperature freezers and blast freezers used for the storage of DNA, RNA, and proteins. These products are sold to universities, government and private research facilities, and biotechnology companies for bioproduction and research purposes.
ISCO
2nd
International Stem Cell
$2.24Mn
0.28
+7.69%
+100.00%
Through its Lifeline Cell Technology business, the company sells over two hundred human cell-based items, including primary cells, stem cells, and specialized media, to academic, government, and industrial laboratories.
HCWB
2nd
HCW Biologics
$2.12Mn
1.60
+4.58%
-94.13%
The company commercializes and sells specific reagents, HCW9201 and HCW9206, which are used by partners to improve the manufacturing of CAR T and natural killer cell therapies.
ISPC
iSpecimen
$1.72Mn
1.13
+3.67%
-96.89%
iSpecimen sells human biospecimens, including biofluids, tissues, and living cells, to life science researchers for use in discovery and development. These products are essential reagents and materials for life-sciences research, fitting the description of tools and consumables for bioproduction and research.
BJDX
2nd
Bluejay Diagnostics
$1.63Mn
0.82
+0.00%
-93.75%
The company is evaluating opportunities to place its analyzers for research use only (RUO) purposes in laboratories and academic institutions, which falls under life-sciences research tools.
BNBX
Bnb Plus
$1.00Mn
0.12
+0.00%
-97.29%
The company's primary revenue is generated through LineaRx, which sells synthetic DNA templates, RNA production enzymes, and mRNA manufacturing kits to biotechnology firms and research institutions. These products are tools and reagents used for life-sciences research and bioproduction.
VNRX
2nd
Volitionrx
$859.93K
0.21
-4.55%
-98.25%
The company sells Capture-Seq™/Capture-PCR™ kits and components to research partners and provides nucleosome profiling services via Nu. Q® Discover for drug developers and scientists.
NUMD
2nd
Nu-Med Plus
$835.48K
0.01
+0.00%
-75.00%
The company offers a 'Research Dilution System' specifically designed for investigational applications in laboratory settings and research institutions to produce high-purity nitric oxide for biomedical research.
FOXO
2nd
Foxo Technologies
$137.98K
0.10
-16.67%
-98.15%
Through Vector BioSource Inc., the company sources, preserves, and distributes human biological specimens (blood, serum, tissues, cells) to pharmaceutical and biotechnology firms for research and development.